Cureclip Pharmaceuticals Limited, a active public limited company, was established on 22 November 1990 in Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230DL1990PLC042161. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹5.73 M.
It upholds a compliant status. Its leadership includes Vivek Goyal (Director), Naresh Kumar Goyal (Director), Manoj Kumar Jha (Additional Director). Past directors included Vivek Goyal, Rakhi, Vinod Kumar. It holds ₹2.10 Cr open charges and ₹12.12 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Unit No. 1273, 12Th Floor, Aggarwal Cyber Plaza 2, Netaji Subash Place, Pitampura, Delhi, Delhi, 110034.
U24230DL1990PLC042161
042161
22 November 1990
₹1.00 Cr
₹5.73 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Cureclip Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vivek Goyal | Director | 15 Dec 2016 | Current |
| Naresh Kumar Goyal | Director | 01 Nov 2005 | Current |
| Manoj Kumar Jha | Additional Director | 01 Apr 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2017 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
| Pramod Abcsdd | Director | 10 Jan 2022 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
| Pramod Abcsdd | Director | 14 Sep 2018 | Past |
| Pramod Abcsdd | Director | 15 Jul 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Maiden Pharmaceuticals Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 8.85% decrease. The company also saw a substantial fall in profitability, with a 466.79% decrease in profit. The company's net worth observed a substantial decline by a decrease of 42.78%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Cureclip Pharmaceuticals had a promoter holding of 89.11% and a public holding of 10.89%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹21,000,000.00
₹121,200,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Jan 2022 | Axis Bank Limited | ₹1.50 Cr | Open |
| 26 Jul 2021 | Others | ₹6.00 M | Open |
| 26 Feb 2022 | Others | ₹4.99 Cr | Satisfied |
| 28 Aug 2002 | Punjab & Sind Bank | ₹4.60 Cr | Satisfied |
| 28 Aug 2002 | Punjab & Sind Bank | ₹7.50 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Cureclip Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Cureclip Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cureclip Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Manoj Kumar Jha was appointed as a Additional Director was appointed as a Additional Director on 01 Apr 2025 & has been associated with this company since 7 months 30 days . was recorded as a recent event.
The activity Cureclip Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Cureclip Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
The activity A charge registered on 26 Feb 2022 via Charge ID 100548885 with Others was fully satisfied on 17 Feb 2023. was completed.
A charge with Others of Rs. 4.99 Cr registered on 26 Feb 2022 with Charge ID 100548885 was modified on 22 Apr 2022. was recorded as a recent event.
The activity A charge registered on 28 Aug 2002 via Charge ID 90054628 with Punjab & Sind Bank was fully satisfied on 21 Apr 2022. was completed.
Maiden Pharmaceuticals, linked to cough syrups associated with child deaths in Gambia, denied tampering with test samples or bribing officials. An investigation by the state of Haryana's Food and Drug Administration is probing whether a state drug regulator was bribed to switch samples tested by the Indian government, contradicting WHO findings. .
The pharma company said, We are shocked to hear the media reports regarding the deaths and deeply saddened on this incident but we received the official information from our agent at the Gambia on October 5, 2022, and on the subsequent date, World Health Organisation alert was issued against us. .
The CIN of Cureclip Pharmaceuticals Limited is U24230DL1990PLC042161.
Cureclip Pharmaceuticals Limited is headquartered at Unit No. 1273, 12Th Floor, Aggarwal Cyber Plaza 2, Netaji Subash Place, Pitampura, Delhi, Delhi, 110034.
Cureclip Pharmaceuticals Limited was incorporated on 22 November 1990.
The current directors of Cureclip Pharmaceuticals Limited are
The primary industry of Cureclip Pharmaceuticals Limited is Manufacturing.
Cureclip Pharmaceuticals Limited is unlisted.
The authorized capital of Cureclip Pharmaceuticals Limited is ₹1.00 Cr, and the paid-up capital is ₹5.73 M.
The compliance status of Cureclip Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX